The following procedure of participation must be followed by any pharmaceutical company which produces drugs and wishes to participate in the 10th World Congress of Melanoma / 17th EADO Congress!

In Italy, each pharmaceutical company that sponsors a meeting or a congress on topics which in anyway are related to the use of their own pharmaceutical products, must submit an application to the competent unit of the Italian Medicines Agency (AIFA) to obtain specific authorization.

The AIFA authorization is not necessary …

  • when a company promotes only advertising medical devices or food supplements during a congress (products without Marketing Authorization).
  • when a company sponsors a meeting on topics not related to the use of any of their own medical products; in this case the company is not allowed to expose or distribute any kind of advertising material during the meeting (Section 9 art. 124 D.L. n.219/06).
The AIFA authorization is necessary …

  • for every pharmaceutical company (Marketing Authorization Holder or the companies responsible for the actual marketing of pharmaceutical products) which sponsors a meeting or a congress on topics related in any way to the use of their own pharmaceutical products.
In order to obtain authorization, an application containing the details of the expenses is to be submitted 60 days before the day of the meeting by the pharmaceutical company (Marketing Authorization Holder or the companies responsible for the actual marketing of pharmaceutical products) to
the competent Unit of AIFA, which will issue its approval after 45 days from the moment the application form has been received.

The authorization procedure is carried out through the AIFA website area ACC (authorization for congresses and meetings) and for this purpose, pharmaceutical companies must be registered.

Further information is available at the following link: https://www.aifa.gov.it.

Our local partner agency Triumph is at your disposal to answer any questions you may have: aifa.wcm2021@thetriumph.com.